27 Fanconi Anemia Clinical Trials in Dallas, TX (2026)

Q: How do I join a clinical trial in Dallas?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you.

Recruiting Fanconi Anemia Studies in Dallas

NCT02693509Recruiting

Get With The Guidelines-Heart Failure Registry

Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on gu...

Dallas, TX128,026 participantsAmerican Heart Association

View Study Details

NCT06593314Recruiting

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies...

Dallas, TXNA800 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT04629014Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using dat...

Dallas, TX750 participantsBoston Children's Hospital

View Study Details

NCT05849077Recruiting

Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)

This study is designed to answer one of the fundamental gaps in knowledge in the resuscitation of preterm infants at birth: What is the optimal target oxygen saturation (SpO2) range that increases sur...

Dallas, TXNA700 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT04493385Recruiting

The Hepatitis C Transplant Collaborative

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable....

Dallas, TX500 participantsBaylor Research Institute

View Study Details

NCT06906367Recruiting

A Study of Patients With Fabry Disease (US Specific)

This is an observational study to evaluate the effects of treatment on long-term effectiveness, safety, and health-related quality of life (HRQOL) in patients with Fabry disease, with a main focus on ...

Dallas, TX450 participantsAmicus Therapeutics

View Study Details

NCT06349941Recruiting

Home-based Cardiac Rehabilitation in Heart Failure

This study evaluates a mobile health (mHealth) home-based cardiac rehabilitation program for patients with heart failure. We will stratify randomization between rural and urban populations, with the g...

Dallas, TXPHASE3332 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06225193Recruiting

Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population

In this initial investigator-initiated retrospective study, aim to analyze the enhanced liver fibrosis (ELF) scores in this high-risk population for NAFLD/nonalcoholic steatohepatitis(NASH)-related fi...

Dallas, TX300 participantsMethodist Health System

View Study Details

NCT06939751Recruiting

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

This study aims to develop and refine a microRNA (miR) biomarker panel that can be used to phenotype net immune state after heart transplantation using circulating miRs (associated with drug doses and...

Dallas, TX250 participantsInova Health Care Services

View Study Details

NCT04982419Recruiting

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, func...

Dallas, TXPHASE2240 participantsVA Office of Research and Development

View Study Details

NCT07508787Recruiting

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

The goal of this clinical trial is to learn if siplizumab can prevent rejection of a kidney transplant in adult participants with end stage kidney disease. The main questions it aims to answer are: H...

Dallas, TXPHASE2120 participantsNefro Avillion Clinical Development, LLC

View Study Details

NCT07223242Recruiting

Tailored Exercise Training Study Among Adults With HFpEF

Heart failure with preserved ejection fraction (HFpEF) is associated with a high morbidity and mortality burden. There are limited pharmacological options available for the treatment of HFpEF. Exercis...

Dallas, TXPHASE2120 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT03906435Recruiting

Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)

This study is being done to see if outcomes for both a premature infant's parents and the infant born prematurely who have spent time in the neonatal intensive care unit (NICU) can be improved through...

Dallas, TXNA100 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06961929Recruiting

IEEM-Heat and Heart Failure

We will test the hypothesis that increasing skin wetness, and thus evaporative cooling, will attenuate the increase in core body temperature and accompanying cardiac stress during heat wave conditions...

Dallas, TXNA88 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT05723679Recruiting

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

The overall purpose of this study is to investigate whether pulmonary limitations that increase the oxygen (O2) cost of breathing impact dyspnea on exertion (DOE) and peak exercise capacity in patient...

Dallas, TXNA78 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06130059Recruiting

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

The purpose of this research study is to determine the effectiveness of low dose colchicine (LoDoCo) on measures of exercise capacity, physical function, frailty, and quality of life, among patients w...

Dallas, TXPHASE260 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT04703842Recruiting

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

It is believed that targeted SERCA2a enzyme replacement in HFrEF patients will correct defective intracellular Ca2+ hemostasis, resulting in improved cardiac contractile function and energetics which ...

Dallas, TXPHASE157 participantsSardocor Corp.

View Study Details

NCT06080074Recruiting

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

There are two primary goals of this multicenter clinical trial that combines an FDA device trial and a phase II drug trial in the same study cohort. These two goals are to: 1. To evaluate the safety ...

Dallas, TXPHASE250 participantsStanford University

View Study Details

NCT06350695Recruiting

The ROle of Compression StocKings in Heart Failure Patients

Congestive heart failure (CHF) occurs when the heart is weak and not able to effectively pump blood to the body. One of the common manifestations of CHF is fluid overload and swelling of the legs. Diu...

Dallas, TXNA50 participantsUniversity of Maryland, Baltimore

View Study Details

NCT07030270Recruiting

Comparing Surfactant Administration Through Supraglottic Airway and Thin Catheter for Preterm Infants

What is this study about? This study is comparing two ways of giving surfactant, a medicine that helps premature infants breathe better. Surfactant can be given using a thin tube ("Less Invasive Surfa...

Dallas, TXNA40 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07109349Recruiting

tAN for First Responders

This study is designed as an open label, single arm, decentralized clinical study in which first responders will receive transcutaneous auricular neurostimulation (tAN), which targets the auricular br...

Dallas, TXNA30 participantsSpark Biomedical, Inc.

View Study Details

NCT04656080Recruiting

Cardiopulmonary Stress Testing (CPET) AlloSure Study

1. Cell-free DNA does not vary significantly as a function of the activity of immunologically quiescent cardiac transplant recipients, despite the metabolic demands of the transplanted organ. (The imp...

Dallas, TX27 participantsBaylor Research Institute

View Study Details

NCT03383419Recruiting

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients

This phase II, multi-center, open-label study will evaluate the safety and efficacy of utilizing HCV-positive donors for heart transplant in HCV-negative recipients treated with sofosbuvir 400 mg / ve...

Dallas, TXPHASE215 participantsBaylor Research Institute

View Study Details

NCT07727538Recruiting

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS....

Dallas, TXPHASE312 participantsIonis Pharmaceuticals, Inc.

View Study Details

NCT06560762Recruiting

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

A Phase 1, Open label, Multiple Ascending Dose Study to Assess Safety and Tolerability of STM-01 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)...

Dallas, TXPHASE112 participantsSecretome Therapeutics

View Study Details

NCT05452720Recruiting

MASA Valve Early Feasibility Study

The MASA Valve Early Feasibility Study (MVEFS) multi-site interventional clinical trial within the United States of America with each center following a common protocol.The objective of the trial is t...

Dallas, TXNA10 participantsPECA Labs

View Study Details

NCT06061549Recruiting

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction

The goal of this clinical trial is to test an experimental gene therapy in participants with heart failure with preserved ejection fraction, also known as diastolic heart failure. The main questions i...

Dallas, TXPHASE110 participantsSardocor Corp.

View Study Details

About Fanconi Anemia Clinical Trials in Dallas

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 27 fanconi anemia clinical trials recruiting participants in Dallas, TX. These studies are seeking a combined 133,227 participants. Research is being sponsored by American Heart Association, University of Texas Southwestern Medical Center, Boston Children's Hospital and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Dallas — FAQ

Are there fanconi anemia clinical trials in Dallas?

Yes, there are 27 fanconi anemia clinical trials currently recruiting in Dallas, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dallas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.

Are clinical trials in Dallas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 27 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated September 6, 2026 from ClinicalTrials.gov